Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 1, 2026

On May 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$71.37 for US$1.07M under a trading plan, leaving 612,540 shares. Filed May 1, 2026 (Form 4).

Sold
15,000 shares
Price
US$71.37 average (US$69.54 to US$74.96)
Value
US$1.07M
Holding after
612,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockSale5,300US$69.54622,240Direct
May 1, 2026Common StockSale3,600US$70.77618,640Direct
May 1, 2026Common StockSale1,000US$71.76617,640Direct
May 1, 2026Common StockSale3,100US$73.14614,540Direct
May 1, 2026Common StockSale1,700US$74.23612,840Direct
May 1, 2026Common StockSale300US$74.96612,540Direct

Source

View original at SEC

Related